CATH Classification
| Level | CATH Code | Description | 
|---|---|---|
|   | 3 | Alpha Beta | 
|   | 3.90 | Alpha-Beta Complex | 
|   | 3.90.340 | Nitric Oxide Synthase; Chain A, domain 1 | 
|   | 3.90.340.10 | Nitric Oxide Synthase; Chain A, domain 1 | 
Domain Context
CATH Clusters
| Superfamily | Nitric Oxide Synthase; Chain A, domain 1 | 
| Functional Family | Nitric oxide synthase, endothelial | 
Enzyme Information
| 1.14.13.39 | Nitric-oxide synthase (NADPH). based on mapping to UniProt P29474 2 L-arginine + 3 NADPH + 4 O(2) = 2 L-citrulline + 2 nitric oxide + 3 NADP(+) + 4 H(2)O. -!- The enzyme consists of linked oxygenase and reductase domains. -!- The eukaryotic enzyme binds FAD, FMN, heme (iron protoporphyrin IX) and tetrahydrobiopterin, and its two domains are linked via a regulatory calmodulin-binding domain. -!- Upon calcium-induced calmodulin binding, the reductase and oxygenase domains form a complex, allowing electrons to flow from NADPH via FAD and FMN to the active center. -!- The reductase domain of the enzyme from the bacterium Sorangium cellulosum utilizes a [2Fe-2S] cluster to transfer the electrons from NADPH to the active center. -!- Cf. EC 1.14.14.47. | 
UniProtKB Entries (1)
| P29474 | NOS3_HUMAN Homo sapiens Nitric oxide synthase, endothelial | 
PDB Structure
| PDB | 1M9Q | 
| External Links | |
| Method | X-RAY DIFFRACTION | 
| Organism | Escherichia | 
| Primary Citation | Conformational Changes in Nitric Oxide Synthases Induced by Chlorzoxazone and Nitroindazoles: Crystallographic and Computational Analyses of Inhibitor Potency Biochemistry | 
